Deep Track Capital, LP - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 93 filers reported holding RELMADA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Deep Track Capital, LP ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,704,319
-35.8%
1,234,773
-0.4%
0.11%
-32.7%
Q1 2024$5,766,158
-31.9%
1,240,034
-39.3%
0.16%
-41.7%
Q4 2023$8,464,259
-0.6%
2,044,507
-28.0%
0.28%
-14.0%
Q3 2023$8,513,454
+22.0%
2,837,8180.0%0.33%
+1.9%
Q2 2023$6,981,032
+8.8%
2,837,8180.0%0.32%
+22.8%
Q1 2023$6,413,469
-35.2%
2,837,8180.0%0.26%
-36.8%
Q4 2022$9,903,985
-53.7%
2,837,818
+390.9%
0.42%
-57.6%
Q3 2022$21,400,000
+125.4%
578,061
+15.6%
0.98%
+57.1%
Q2 2022$9,495,000
+244.5%
500,000
+389.6%
0.62%
+252.5%
Q1 2022$2,756,000102,1170.18%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
VR Adviser, LLC 2,270,072$61,269,0009.93%
GREAT POINT PARTNERS LLC 790,000$21,322,0005.15%
ACUTA CAPITAL PARTNERS, LLC 342,000$9,231,0004.31%
COWEN AND COMPANY, LLC 1,164,361$31,426,0003.02%
Altium Capital Management LP 206,000$5,560,0001.86%
BVF INC/IL 1,647,400$44,463,0001.78%
RTW INVESTMENTS, LP 2,540,074$68,557,0001.42%
Vivo Capital, LLC 705,882$19,052,0001.31%
RA Capital Management 2,000,000$53,980,0001.18%
SPHERA FUNDS MANAGEMENT LTD. 291,252$7,861,0001.11%
View complete list of RELMADA THERAPEUTICS INC shareholders